Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
- PMID: 32100488
- PMCID: PMC7044007
- DOI: 10.3802/jgo.2020.31.e43
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment in
-
In reply: the evaluation of IgG titers' stability from blood samples is necessary.J Gynecol Oncol. 2020 Mar;31(2):e44. doi: 10.3802/jgo.2020.31.e44. J Gynecol Oncol. 2020. PMID: 32100489 Free PMC article. No abstract available.
Comment on
-
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2019 Nov;30(6):e88. doi: 10.3802/jgo.2019.30.e88. J Gynecol Oncol. 2019. PMID: 31576684 Free PMC article. Clinical Trial.
